SEARCH RESULTS FOR: "Tag: ACAD"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(3)
2018(6)
2017(7)
2016(20)
2015(14)
CATEGORIES
Analyst Downgrades(2)
Analyst Update(7)
Analyst Upgrades(2)
Buzz Stocks(7)
By the Numbers(1)
Earnings Preview(1)
Expectational Analysis(2)
General(7)
Intraday Option Activity(7)
Market Recap(2)
Midday Market Check(7)
Opening View(4)
Quantitative Analysis(1)
Stock Market News(4)
Stocks On the Move(8)

11/26/2019 9:32 AM
It's been a huge year for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), thanks to positive updates for its drugs Nuplazid and pimavanserin, the latter of which again has the pharma name in focus. The ...
10/1/2019 9:14 AM
U.S. stock market futures are trading above fair value this morning, pointing toward a strong start to the fourth quarter for the Dow Jones Industrial Average (DJI). Today's session features a num...
9/9/2019 10:26 AM
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced positive late-stage data for its drug pimavanserin in patents suffering from dementia-related psychosis. The San Diego-based biopharmaceutical firm ...
9/21/2018 9:53 AM
Shares of San Diego-based drug concern ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) are continuing yesterday's surge, with a 6.7% advance to trade at $20.39 out of the gate. Just one day after the Food a...
8/9/2018 10:45 AM
Shares of drug name ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) touched a five-year low of $12.77 out of the gate, but have since turned higher, as traders shrug off an earnings miss. The firm reported...
Partner Center